Forefront Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$709K Buy
771
+40
+5% +$40.6K 0.3% 75
2025
Q4
$786K Sell
731
-10
-1% -$9.56K 0.37% 62
2025
Q3
$566K Buy
741
+193
+35% +$144K 0.14% 121
2025
Q2
$423K Sell
548
-105
-16% -$81.6K 0.29% 68
2025
Q1
$539K Buy
653
+105
+19% +$87.4K 0.37% 64
2024
Q4
$423K Buy
+548
New +$454K 0.32% 65

Other funds holding LLY

Forefront Wealth Partners's LLY Position: Q1 2026 in Review

Forefront Wealth Partners increased its Eli Lilly (LLY) stake by 5.5% in Q1 2026, buying an estimated $40.6K and bringing the position to 771 shares worth $709K. The position accounts for 0.3% of the portfolio, ranked #75.

Forefront Wealth Partners first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $786K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Forefront Wealth Partners held 771 shares of Eli Lilly worth $709K as of Q1 2026.
  • Forefront Wealth Partners bought 40 Eli Lilly shares in Q1 2026, an estimated $40.6K.
  • Eli Lilly made up 0.3% of Forefront Wealth Partners's portfolio in Q1 2026, its #75 holding.
  • Forefront Wealth Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Forefront Wealth Partners's Eli Lilly position peaked at $786K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Forefront Wealth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.